Endometriosis is a disease. The World Health Organization classifies it as a chronic disease, and it is recognized as such by major medical organizations worldwide. This isn’t a minor distinction: calling endometriosis a disease rather than a “condition” or “women’s problem” reflects the seriousness of what it does to the body and has real implications for research funding, insurance coverage, and how patients are treated in clinical settings.
What Makes Endometriosis a Disease
A disease involves a specific pathological process that disrupts normal body function. Endometriosis fits that definition clearly. Tissue similar to the lining of the uterus grows in places it shouldn’t, most commonly on the ovaries, fallopian tubes, and the tissue lining the pelvis. Unlike the uterine lining, which sheds during a period, this displaced tissue has no way to exit the body. It bleeds, breaks down, and becomes trapped, triggering a cascade of problems.
The body responds to this trapped tissue with chronic inflammation. Immune cells move in and release inflammatory signals, which in turn interact with estrogen and other hormones to create a self-reinforcing loop. Estrogen promotes the survival of the misplaced tissue, which produces more inflammatory compounds, which stimulate more estrogen production. This cycle drives persistent pain, tissue damage, and the formation of scar tissue and adhesions that can bind organs together.
Growing evidence now frames endometriosis as a systemic inflammatory disease rather than a localized pelvic problem. Researchers have found associations between endometriosis and conditions affecting blood vessels, including cardiovascular disease and pre-eclampsia. The chronic inflammation doesn’t stay confined to the pelvis. Inflammatory markers, particularly a protein called TNF-alpha, are elevated throughout the body and are being investigated as a potential blood-based marker for the disease.
How Endometriosis Is Staged
The American Society for Reproductive Medicine uses a four-stage classification system based on the size and location of endometrial growths, plus the severity of any adhesions on the ovaries, peritoneum (the membrane lining the abdomen), and fallopian tubes. Each factor receives a weighted score, and the total determines the stage:
- Stage I (1 to 5 points): Mild, with small, scattered growths and minimal scarring.
- Stage II (6 to 15 points): Moderate, with more implants that may be deeper.
- Stage III (16 to 30 points): Severe, often involving cysts on the ovaries (endometriomas) and significant adhesions.
- Stage IV (31 to 54 points): Extensive, with large cysts, dense adhesions, and widespread deep implants.
One important caveat: the stage doesn’t reliably predict pain levels. Some people with Stage I experience debilitating symptoms, while others with Stage IV have relatively little pain. The staging system is most useful for describing the physical extent of the disease, particularly when planning surgery or evaluating fertility.
Symptoms Beyond Period Pain
The hallmark symptom is severe pain during menstruation, but endometriosis causes problems well beyond the days of a period. Chronic pelvic pain that persists throughout the month is common. Heavy menstrual bleeding, pain during or after sex, abdominal bloating, nausea, and fatigue are all part of the picture. Infertility affects a significant proportion of people with the disease.
Because these symptoms overlap with other conditions and because period pain is so often dismissed as normal, diagnosis takes far too long. In the United Kingdom, the average delay from first symptoms to a confirmed diagnosis is roughly 8 to 10 years. That gap represents years of pain, missed work, and medical appointments that don’t lead to answers. Historically, a definitive diagnosis required laparoscopic surgery to visually confirm the tissue, though guidelines are shifting toward clinical diagnosis based on symptoms, imaging, and physical examination to reduce that delay.
How Endometriosis Is Treated
There is no cure. Treatment focuses on managing pain, slowing the growth of endometrial tissue, and preserving or restoring fertility when needed.
Hormonal therapies are the first-line approach for pain. These work by suppressing the estrogen that fuels the disease. Options include combined hormonal contraceptives (pill, patch, or vaginal ring), progestogen-only treatments, hormonal intrauterine devices, and subdermal implants. Anti-inflammatory pain relievers can be used alongside hormonal treatment or on their own for symptom relief. Finding the right combination often takes time and trial and error, and some people experience side effects that limit which options work for them.
Surgery becomes relevant when hormonal treatment isn’t effective, when there are large ovarian cysts (endometriomas), or when fertility is a priority. The preferred surgical technique is excision, which involves cutting out endometrial implants rather than burning them away, because excision is associated with lower recurrence rates. For ovarian endometriomas, removing the cyst wall (cystectomy) is more effective than simply draining the cyst. Surgery can provide significant relief, but the disease recurs in a substantial number of cases, and repeat procedures are common.
The Financial Weight of the Disease
Endometriosis carries a staggering economic burden. In the United States, the combined cost of direct healthcare and lost productivity was estimated at $69.4 billion as of 2009, and the figure has only grown since. On an individual level, people with endometriosis spend roughly $11,700 per year on healthcare in the year after diagnosis, compared to about $5,200 for similar patients without the disease. That $6,500 annual difference covers more frequent doctor visits, imaging, prescriptions, emergency care, and surgeries, but it doesn’t capture the lost wages, reduced career advancement, and diminished quality of life that come with managing a chronic pain condition for decades.
These numbers reinforce why the “disease” label matters. Diseases attract research dollars, shape insurance policy, and influence how seriously symptoms are taken in a clinical encounter. For a condition that takes nearly a decade to diagnose and costs thousands of dollars a year to manage, that recognition is overdue but firmly established.